International Journal of Stem Cells
Scope & Guideline
Catalyzing Innovations in Stem Cell Applications
Introduction
Aims and Scopes
- Stem Cell Biology and Therapeutics:
The journal emphasizes research on the biology of various stem cell types, including pluripotent and multipotent stem cells, and their potential therapeutic applications in regenerative medicine, such as tissue repair and organ regeneration. - Organoid Technology:
A significant area of focus is on the development and application of organoids, which are three-dimensional structures derived from stem cells that mimic organ functions. This includes guidelines for organoid manufacturing and studies on organoid systems for disease modeling. - Stem Cell Imaging and Characterization:
Research involving advanced imaging techniques to characterize stem cells and their differentiations, as well as the application of single-cell technologies to understand cellular heterogeneity within stem cell populations. - Stem Cell Engineering and Manipulation:
The journal covers methodologies for engineering stem cells, including genetic manipulation techniques like CRISPR/Cas9, to enhance their therapeutic efficacy and understand the underlying mechanisms of stem cell differentiation. - Stem Cell Interaction with Microenvironment:
Studies on how stem cells interact with their microenvironment, including immune interactions, extracellular vesicles, and the influence of biochemical signals on stem cell behavior and fate. - Clinical Applications and Safety Studies:
The journal publishes research on the clinical applications of stem cell therapies, including safety assessments, efficacy studies, and the challenges associated with translating stem cell research into clinical practice.
Trending and Emerging
- Advanced Organoid Models:
There is a noticeable increase in research focusing on organoid technology, with studies exploring the development of organoids from various stem cell types for applications in drug testing, disease modeling, and regenerative medicine. - Stem Cell Genomics and Single-Cell Omics:
The use of genomics and single-cell omics technologies is gaining momentum, allowing for a deeper understanding of stem cell heterogeneity, lineage tracing, and the regulatory networks governing stem cell behavior. - Stem Cell Therapy for Neurological Disorders:
An emerging focus is on the use of stem cells for treating neurological disorders, including applications of iPSCs in modeling diseases like Parkinson's and Huntington's, as well as exploring potential therapeutic avenues. - Immunomodulatory Properties of Stem Cells:
Research on the immunomodulatory effects of stem cells, particularly mesenchymal stem cells, is trending, highlighting their potential in treating autoimmune diseases and enhancing tissue repair. - Bioengineering and Stem Cell Applications:
There is a growing interest in bioengineering approaches to enhance stem cell therapies, including the development of biomaterials and scaffolds that support stem cell growth and differentiation. - CRISPR/Cas9 and Gene Editing Technologies:
The application of gene editing technologies, particularly CRISPR/Cas9, is increasingly prevalent in stem cell research, enabling precise modifications that enhance therapeutic potential or study disease mechanisms.
Declining or Waning
- Traditional Differentiation Protocols:
Research focused on basic differentiation protocols for stem cells has decreased as more sophisticated techniques, such as organoid formation and bioengineering approaches, gain traction. - Basic Stem Cell Characterization Studies:
There has been a waning interest in purely descriptive studies that characterize stem cells without applying them to therapeutic contexts or advanced applications. - Non-therapeutic Applications of Stem Cells:
Studies that focus solely on the basic biology of stem cells without direct implications for therapy or disease modeling are becoming less frequent as the field moves towards more applied research. - Limited Focus on Ethical Implications:
Discussions and studies addressing the ethical implications of stem cell research and therapies have diminished, likely due to an increased focus on technological advancements and clinical applications. - Non-embryonic Stem Cell Research:
Research on non-embryonic stem cells, such as adult stem cells, appears to be declining in favor of studies on induced pluripotent stem cells (iPSCs) and their applications.
Similar Journals
Regenerative Engineering and Translational Medicine
Driving Innovation at the Intersection of Science and HealthRegenerative Engineering and Translational Medicine is an esteemed academic journal published by Springer Heidelberg, focusing on the interdisciplinary fields of biomaterials, biomedical engineering, and cell biology. With an ISSN of 2364-4133 and an E-ISSN of 2364-4141, the journal has carved a niche for itself since its inception in 2015, showcasing cutting-edge research that bridges the gap between scientific findings and practical applications in regenerative medicine. As a recognized platform in its field, it is currently positioned within Q3 quartiles in biomaterials, biomedical engineering, and medicine (miscellaneous), with a Scopus ranking that reflects its growing influence among peers. The journal aims to disseminate high-quality, peer-reviewed articles that highlight advancements in regenerative engineering, further advancing both theoretical and applied research. Scholars and practitioners seeking to stay at the forefront of the ever-evolving landscape of regenerative health solutions will find invaluable insights and innovations within these pages. Join a community of leading thinkers and explore the journal's comprehensive research contributions, which are crucial for fostering partnerships between academia and industry in the quest for transformative medical solutions.
BIOCELL
Exploring the Depths of Biochemistry and GeneticsBIOCELL is a distinguished peer-reviewed journal dedicated to the field of Cell Biology, published by TECH SCIENCE PRESS. Since its inception in 1995, the journal has been at the forefront of disseminating innovative research, with converged publication years extending from 1995 to 2013 and from 2015 to 2024. Although it currently holds a Q4 ranking in the Cell Biology category according to the 2023 category quartiles, BIOCELL aims to foster advancements by providing a platform for researchers, professionals, and students to share their findings in biochemistry, genetics, and molecular biology. The journal is available in both print (ISSN: 0327-9545) and digital formats (E-ISSN: 1667-5746) and seeks to attract contributions that enhance scholarly dialogue and understandings of cellular mechanisms and innovations. With a commitment to quality research and critical discourse, BIOCELL plays an important role in nurturing the scientific community within Argentina and beyond, offering vital insights that contribute to the advancement of the life sciences.
Journal of Tissue Engineering and Regenerative Medicine
Advancing the frontiers of tissue engineering and regenerative medicine.Journal of Tissue Engineering and Regenerative Medicine, published by WILEY, stands as a pivotal platform in the fields of biomaterials, biomedical engineering, and regenerative medicine. With an ISSN of 1932-6254 and an E-ISSN of 1932-7005, this journal, based in the United Kingdom, has consistently delivered high-quality research since its inception in 2006, converging critical insights through 2024. With an impressive citation profile reflected in its Scopus rankings—specifically a rank of #58 in Medicine and #75 in Biomedical Engineering—the journal is acknowledged for its substantial impact, as demonstrated by its competitive quartile standings in 2023. Notably, it maintains a Q3 ranking in Biomaterials and Q2 in both Biomedical Engineering and Medicine (miscellaneous), showcasing its influence and relevance in the rapidly evolving interplay between engineering and medicine. The journal serves as a vital resource for researchers and practitioners aiming to stay abreast of innovations and breakthroughs in regenerative therapies, tissue scaffolds, and biomaterials. While not an open-access publication, it fosters academic dialogue and knowledge dissemination that is crucial for advancing the field.
Cellular Reprogramming
Exploring New Frontiers in Stem Cell ResearchCellular Reprogramming is a prominent academic journal published by MARY ANN LIEBERT, INC, dedicated to advancing the field of cellular biology and biotechnology. With its ISSN 2152-4971 and E-ISSN 2152-4998, this journal provides an innovative platform for researchers and professionals to share groundbreaking research findings on cellular reprogramming, stem cell biology, and regenerative medicine. Established in 2010, and actively publishing until 2024, the journal is recognized for its contributions, evidenced by its categorizations in the Q3 and Q4 quartiles across several related fields, including biotechnology and developmental biology. This peer-reviewed journal not only supports open access to scientific literature but also aims to enhance interdisciplinary collaboration among scientists. With a growing impact in the realms of biochemistry, genetics, and molecular biology, Cellular Reprogramming remains an essential resource for the dissemination of pioneering research that could shape the future of cellular therapies.
Regenerative Medicine
Pioneering Discoveries in Biomedical RegenerationRegenerative Medicine, published by Taylor & Francis Ltd, is a pivotal journal within the field of biomedical research, focusing on the innovative advances in regenerative and restored functions in human health. With an ISSN of 1746-0751 and an E-ISSN of 1746-076X, this esteemed journal boasts a commendable impact factor within its categories, notably holding the Q2 status in Embryology and Q3 in Biomedical Engineering as of 2023. Covering a broad spectrum of topics from stem cell research to tissue engineering, it serves as a crucial platform for interdisciplinary collaboration among researchers, professionals, and students dedicated to the regeneration of tissues and organs. Given its comprehensive scope from 2006 to 2024, the journal continues to attract high-quality manuscripts that advance the frontiers of knowledge in regenerative medicine. Researchers and practitioners alike are encouraged to engage with the latest findings and methodologies disseminated in this vital publication.
Stem Cells Translational Medicine
Bridging Research and Real-World ImpactStem Cells Translational Medicine, published by Oxford University Press, is a leading open-access journal that has been at the forefront of stem cell research since its launch in 2012. With an impressive impact across various categories, it occupies Q2 in Cell Biology and is highly recognized in Q1 for both Developmental Biology and Miscellaneous Medicine in 2023. Its strong Scopus rankings highlight its significance in the fields of Biochemistry, Genetics, and Molecular Biology, achieving an outstanding percentile ranking of 93rd in Developmental Biology. The journal provides a pivotal platform for researchers, professionals, and students to publish and access cutting-edge findings that contribute to the understanding and application of stem cell technology. With a commitment to disseminating high-quality scientific knowledge, Stem Cells Translational Medicine plays a vital role in advancing research and innovation within the rapidly evolving landscape of regenerative medicine.
EXPERIMENTAL CELL RESEARCH
Fostering Collaboration in Cell Biology ResearchEXPERIMENTAL CELL RESEARCH is a highly respected journal published by Elsevier Inc, specializing in the dynamic and ever-evolving field of Cell Biology. With an impact factor positioned in the Q2 quartile for 2023, it ranks at the 124th position out of 285 in the Scopus Ranks, indicating a solid reputation among peers in the domains of biochemistry, genetics, and molecular biology. Since its inception in 1950, the journal has contributed significantly to the dissemination of groundbreaking research, providing a platform for studies that explore the nuances of cellular mechanisms, processes, and experimental methodologies. Although the journal currently does not offer open access, its commitment to high-quality, peer-reviewed research continues to attract submissions from leading scientists and scholars across the globe. Researchers, professionals, and students alike will find this journal an invaluable resource for keeping abreast of current developments and innovative breakthroughs in cellular science.
Cells
Connecting Scientists to the Latest in Cellular DiscoveriesCells, published by MDPI in Switzerland, is a leading open-access journal that has been disseminating groundbreaking research in the fields of Biochemistry, Genetics, and Molecular Biology since its inception in 2011. With an impressive E-ISSN of 2073-4409, the journal boasts a strong impact factor and ranks in the 84th percentile for Scopus ratings, underscoring its significance in advancing scientific knowledge. As a Q1-ranked journal in both 2023 and 2020, it serves as a premier platform for researchers, professionals, and students eager to explore innovative findings and methodologies. By providing unrestricted access to high-quality research, Cells plays a pivotal role in facilitating collaboration and inspiration within the global scientific community, making it an indispensable resource for anyone interested in cutting-edge discoveries in cellular biology.
Regenerative Therapy
Advancing regenerative medicine through open access innovation.Regenerative Therapy is a premier open-access journal dedicated to advancing the fields of biomaterials, biomedical engineering, and developmental biology. Published by Elsevier in Japan, this journal has been an influential platform since its inception in 2015, contributing significantly to the global discourse on regenerative medicine. With an impressive Q2 ranking in major categories such as Biomaterials and Biomedical Engineering, it is recognized for its quality of research and innovation. Researchers seeking to disseminate their findings or explore cutting-edge developments will find Regenerative Therapy to be invaluable, reflecting current trends and fostering collaborations across interdisciplinary boundaries. The journal offers open access, ensuring that high-quality research is available to a broad audience and enhances the impact of scholarly work in the regenerative medicine community.
Stem Cell Reviews and Reports
Illuminating Pathways in Stem Cell ScienceStem Cell Reviews and Reports is a prestigious journal published by SPRINGER specializing in the dynamic field of stem cell research, encompassing various aspects of cell biology and cancer research. With an ISSN of 2629-3269 and E-ISSN of 2629-3277, this journal serves as an essential resource for academics, offering insightful reviews and cutting-edge reports from 2009 to 2024. The journal has achieved a commendable Q2 ranking in both Cancer Research and Cell Biology categories as of 2023, highlighting its significant contribution to the scientific community. Additionally, with Scopus rankings placing it in the 74th percentile for both biochemistry and cell biology, it is recognized for its high-quality articles that foster innovative approaches in stem cell therapy and regenerative medicine. As an Open Access publication, Stem Cell Reviews and Reports ensures that its comprehensive content is readily available to researchers, professionals, and students, promoting collaboration and advancement in this vital area of study.